CAJ | 학술논문

目的探讨血塞通片联合眩晕宁治疗眩晕症的临床疗效及安全性.方法随机抽取门诊及住院脑动脉硬化症以眩晕为主要症状的70例患者,随机分成治疗组和对照组,其中血塞通片联合眩晕宁为治疗组35例,血塞通片口服3次/d,100 mg/次,眩晕宁口服3片/次,3次/d,饭后服用,连用15天；西比灵为对照组,口服西比灵1次/d,5~10mg/次,连用15天,观察两组治疗效果.结果治疗组总有效率达94.2%,明显高于对照组的80.0%(P<0.05).结论血塞通片联合眩晕宁治疗脑动脉硬化性眩晕疗效显著,值得在临床上推广应用.
목적탐토혈새통편연합현훈저치료현훈증적림상료효급안전성.방법수궤추취문진급주원뇌동맥경화증이현훈위주요증상적70례환자,수궤분성치료조화대조조,기중혈새통편연합현훈저위치료조35례,혈새통편구복3차/d,100 mg/차,현훈저구복3편/차,3차/d,반후복용,련용15천；서비령위대조조,구복서비령1차/d,5~10mg/차,련용15천,관찰량조치료효과.결과치료조총유효솔체94.2%,명현고우대조조적80.0%(P<0.05).결론혈새통편연합현훈저치료뇌동맥경화성현훈료효현저,치득재림상상추엄응용.
Objective Investigate the clinical efficacy and safety of the treatment of vertigo in Xuesaitong tablet combined with vertigo rather. Method Random sample of outpatient and inpatient cerebral arteriosclerosis vertigo as the main symptoms of 70 patients were randomly divided into treatment and control groups, which Xuesaitong tablet combined with vertigo rather for the treatment of 35 cases, Xuesaitong tablet three times a day, once100 mg, dizziness rather orally once three times a day, after meals, once every 15 days; Sibelium control group, oral Sibelium once a day, once 10 ~20 mg of atorvastatin for 15 days, were observed treatment effect.Result The total effective rate of treatment group, 94.2%, significantly higher than 80.0% (P <0.05). Conclusion Xuesaitong tablet combined with vertigo rather the treatment of cerebral arteriosclerosis, vertigo significant, worthy of clinical application.